Correlation Between Bristol-Myers Squibb and HITHINK ROYALFLUSH

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol-Myers Squibb and HITHINK ROYALFLUSH at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol-Myers Squibb and HITHINK ROYALFLUSH into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol-Myers Squibb and HITHINK ROYALFLUSH, you can compare the effects of market volatilities on Bristol-Myers Squibb and HITHINK ROYALFLUSH and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol-Myers Squibb with a short position of HITHINK ROYALFLUSH. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol-Myers Squibb and HITHINK ROYALFLUSH.

Diversification Opportunities for Bristol-Myers Squibb and HITHINK ROYALFLUSH

0.55
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Bristol-Myers and HITHINK is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Bristol-Myers Squibb and HITHINK ROYALFLUSH in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HITHINK ROYALFLUSH and Bristol-Myers Squibb is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol-Myers Squibb are associated (or correlated) with HITHINK ROYALFLUSH. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HITHINK ROYALFLUSH has no effect on the direction of Bristol-Myers Squibb i.e., Bristol-Myers Squibb and HITHINK ROYALFLUSH go up and down completely randomly.

Pair Corralation between Bristol-Myers Squibb and HITHINK ROYALFLUSH

Considering the 90-day investment horizon Bristol-Myers Squibb is expected to generate 0.82 times more return on investment than HITHINK ROYALFLUSH. However, Bristol-Myers Squibb is 1.22 times less risky than HITHINK ROYALFLUSH. It trades about 0.21 of its potential returns per unit of risk. HITHINK ROYALFLUSH is currently generating about -0.23 per unit of risk. If you would invest  6,675  in Bristol-Myers Squibb on June 28, 2022 and sell it today you would earn a total of  396.00  from holding Bristol-Myers Squibb or generate 5.93% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy85.0%
ValuesDaily Returns

Bristol-Myers Squibb  vs.  HITHINK ROYALFLUSH

 Performance (%) 
       Timeline  
Bristol-Myers Squibb 
Bristol-Myers Performance
0 of 100
Over the last 90 days Bristol-Myers Squibb has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest sluggish performance, the Stock's primary indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Bristol-Myers Price Channel

HITHINK ROYALFLUSH 
HITHINK Performance
0 of 100
Over the last 90 days HITHINK ROYALFLUSH has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in October 2022. The current disturbance may also be a sign of long term up-swing for the company investors.

HITHINK Price Channel

Bristol-Myers Squibb and HITHINK ROYALFLUSH Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol-Myers Squibb and HITHINK ROYALFLUSH

The main advantage of trading using opposite Bristol-Myers Squibb and HITHINK ROYALFLUSH positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol-Myers Squibb position performs unexpectedly, HITHINK ROYALFLUSH can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HITHINK ROYALFLUSH will offset losses from the drop in HITHINK ROYALFLUSH's long position.
Bristol-Myers Squibb vs. Sigma Lithium Corp
The idea behind Bristol-Myers Squibb and HITHINK ROYALFLUSH pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
HITHINK ROYALFLUSH vs. SHENZHEN FORTUNE TREND
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Probability Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go